Floatz logo

62 assets in Brain Neoplasm

Therapeutic assets addressing Brain Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Temsirolimus
Brain Neoplasm
M.D. Anderson Cancer CenterP2BBB (72)
Dexmedetomidine
Brain Neoplasm
Kaohsiung Medical University Chung-Ho Memorial HospitalP4BB (69)
Nivolumab
Brain Neoplasm
InSightecP3BB (68)
Cyclophosphamide
Brain Neoplasm
Essen BiotechP3BB (67)
Nogitecan
Brain Neoplasm
Jeffrey N. BruceP2BB (67)
Camustine
Brain Neoplasm
Washington University School of MedicineP2BB (66)
Irinotecan
Brain Neoplasm
NaviFUS CorporationP3BB (66)
Pembrolizumab
Brain Neoplasm
Essen BiotechP3BB (65)
Abemaciclib
Brain Neoplasm
Tango Therapeutics, Inc.P2BB (64)
Propofol
Brain Neoplasm
Kaohsiung Medical University Chung-Ho Memorial HospitalP4B (62)
Sevoflurane
Brain Neoplasm
Kaohsiung Medical University Chung-Ho Memorial HospitalP4B (62)
Memantine
Brain Neoplasm
The University of Texas Health Science Center at San AntonioP3B (61)
Cetuximab
Brain Neoplasm
Northwell HealthP2B (60)
(±)-2-(O-Chlorophenyl)-2-(Methylamino)Cyclohexanone
Brain Neoplasm
Children's Cancer Hospital Egypt 57357P3B (57)
Atezolizumab
Brain Neoplasm
InSightecP3B (57)
Entrectinib
Brain Neoplasm
Cancer Research UKP2/3B (57)
FDOPA
Brain Neoplasm
University of AlbertaP3B (57)
Fentanyl
Brain Neoplasm
Children's Cancer Hospital Egypt 57357P3B (57)
Furosemide
Brain Neoplasm
University of AlbertaP3B (57)
Immunoglobulin G4, Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Regn2810 Heavy Chain), Disulfide With Human Monoclonal Regn2810 .Kappa.-Chain, Dimer
Brain Neoplasm
InSightecP3B (57)
Mannitol
Brain Neoplasm
Northwell HealthP2B (57)
Microbubble
Brain Neoplasm
NaviFUS CorporationP3B (57)
Rvp-001
Brain Neoplasm
Reveal Pharmaceuticals Inc.P2B (57)
Ipilimumab
Brain Neoplasm
InSightecP3B (56)
Niraparib
Brain Neoplasm
Ivy Brain Tumor CenterP3B (56)
Aguix
Brain Neoplasm
Brigham and Women's HospitalP2CCC (53)
Fludarabine
Brain Neoplasm
Essen BiotechP1/2CCC (53)
Fludeoxyglucose
Brain Neoplasm
Peking Union Medical College HospitalP1/2CCC (53)
Nabiximols
Brain Neoplasm
University of BirminghamP2CCC (53)
Raloxifene
Brain Neoplasm
The University of Texas Health Science Center at San AntonioP2CCC (53)
Sgm-101
Brain Neoplasm
Leiden University Medical CenterP2CCC (53)
Sitagliptin
Brain Neoplasm
Case Comprehensive Cancer CenterP2CCC (53)
Vebreltinib
Brain Neoplasm
Apollomics Inc.P2CCC (53)
TIL
Brain Neoplasm
Essen BiotechP1/2CCC (50)
Elacestrant
Brain Neoplasm
Stemline Therapeutics, Inc.P1/2CCC (48)
Capecitabine
Brain Neoplasm
Northwell HealthP1/2CC (45)
Sulfur Hexafluoride
Brain Neoplasm
NaviFUS CorporationP1/2CC (45)
tng456
Brain Neoplasm
Tango Therapeutics, Inc.P1/2CC (45)
Claturafenib
Brain Neoplasm
PfizerP1CC (43)
Dapagliflozin
Brain Neoplasm
Washington University School of MedicineP1CC (43)
Dasatinib
Brain Neoplasm
M.D. Anderson Cancer CenterP1CC (43)
G 207
Brain Neoplasm
M.D. Anderson Cancer CenterP1CC (43)
Iopofosine (¹³¹I)
Brain Neoplasm
Cellectar Biosciences, Inc.P1CC (43)
JYP0322
Brain Neoplasm
Guangzhou JOYO Pharma Co., LtdP1CC (43)
mt027
Brain Neoplasm
Suzhou Maximum Bio-tech Co., Ltd.P1CC (43)
pf-07799544
Brain Neoplasm
PfizerP1CC (43)
Ad5-yCD
Brain Neoplasm
Henry Ford Health SystemP1CC (41)
ad5-ycd/muttksr39rep-adp adenovirus
Brain Neoplasm
Henry Ford Health SystemP1CC (41)
Brodalumab
Brain Neoplasm
Brian Henick, MDP1CC (41)
Maprotiline
Brain Neoplasm
University of RochesterP1CC (41)
Showing 1 to 50 of 62 assets
PreviousPage 1 of 2Next